Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer
Non-genetic health professionals (NGHPs) have insufficient knowledge of cancer genetics,
express educational needs and are unprepared to counsel their patients regarding their …
express educational needs and are unprepared to counsel their patients regarding their …
[HTML][HTML] Knowledge, perceptions, attitudes, and barriers pertaining to genetic literacy among surgeons: a scoping review
Background: The rapid evolution of genetic technologies and utilization of genetic
information for clinical decision-making has necessitated increased surgeon participation in …
information for clinical decision-making has necessitated increased surgeon participation in …
Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study
WC Birmingham, N Agarwal, W Kohlmann… - BMC Health Services …, 2013 - Springer
Background The strong association between family history and prostate cancer (PCa)
suggests a significant genetic contribution, yet specific highly penetrant PCa susceptibility …
suggests a significant genetic contribution, yet specific highly penetrant PCa susceptibility …
Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing
I Teng, A Spigelman - Familial cancer, 2014 - Springer
Genetic testing for susceptibility for common cancers is widely available. Thus, doctors have
a role in identifying and referring patients who would benefit from a consultation with a …
a role in identifying and referring patients who would benefit from a consultation with a …
Urologists' current practices in screening and treating men with a family history of prostate Cancer
L Rudichuk, KJ Vogel, C Wang, BT Helfand, CG Selkirk - Urology, 2017 - Elsevier
Objective To assess urologists' knowledge and utilization of family history to determine
prostate cancer (PC) screening and treatment recommendations. Materials and Methods …
prostate cancer (PC) screening and treatment recommendations. Materials and Methods …
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review
N Armstrong, RGW Quek, S Ryder, J Ross… - Future …, 2021 - Taylor & Francis
Background: Ongoing clinical trials are investigating PARP inhibitors to target the DNA
damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide …
damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide …
[HTML][HTML] Biopsia de próstata en pacientes con diagnóstico clínico de hiperplasia prostática benigna y relación con el antígeno prostático específico
A Zonana-Nacach, CA Figueroa-Torres… - Revista Mexicana de …, 2014 - Elsevier
Introducción La hiperplasia prostática benigna (HBP) es el tumor benigno más frecuente en
varones por arriba de los 50 años. La sospecha inicial de cáncer de próstata se basa en un …
varones por arriba de los 50 años. La sospecha inicial de cáncer de próstata se basa en un …
Current knowledge and opinions of medical trainees regarding PSA screening
T Sheetz, S Amin, D Diab, N Payne, T Posid - Journal of Cancer Education, 2020 - Springer
After 2008 and 2012 USPSTF recommendations against PSA screening, studies revealed a
decline in screening rates and trend towards more advanced disease at presentation. After …
decline in screening rates and trend towards more advanced disease at presentation. After …
[PDF][PDF] De zoektocht naar markers voor agressieve prostaatkanker
R Cremers - Ned Tijdschr Oncol, 2015 - ariez.nl
Prostaatkanker is een heterogene ziekte, die curatief kan worden behandeld wanneer deze
vroeg wordt ontdekt. Desondanks is de huidige consensus dat populatiebreed screenen …
vroeg wordt ontdekt. Desondanks is de huidige consensus dat populatiebreed screenen …